Sarah Johnson PhD U.S. FDA

Sarah Johnson is a Senior Biologist in the Office of Biotechnology Products and a member of the CDER Manufacturing Science & Innovation Center of Excellence. She has been with CDER/OPQ since 2015. Over the past years, she has extensively studied various aspects of recombinant protein manufacturing focusing on regulatory concerns associated with emerging manufacturing technologies and the viral safety of downstream bioprocessing. Her current research topics include aspects of advanced manufacturing with a focus on continuous bioprocessing to provide regulatory support for the CDER Emerging Technology Program submissions. She has won several internal scientific awards from the FDA and is an author of numerous scientific articles related to biotechnology manufacturing.